Category: Health & Medicines > Medicines > Glipizide
Country/Region: China State/Province: Guangdong
Main Products: API And Intermediate
Business Type: Manufacturer, Retailer
Year Established: 2009
Employees: 501 - 1000 People
Plant Area: 5,000-10,000 square meters
Main Markets: South America 9% Africa 8% Eastern Asia 11% Domestic Market 8% North America 11% Eastern Europe 10% Southern Europe 9% Mid East 11% Northern Europe 8% Oceania 15%
Trade Capacity: FOB, CIF, DDU
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Shangrao
Annual Revenue: confidential
Total Revenue: US$2.5 Million - US$5 Million
Export Revenue: US$50 Million - US$100 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 91% - 100%
Payment Modes: USD, JPY, CHF
Lead Time: 24 days
Import/Export Mode: LLC (Limited Liability Corp)